Glow-in-the-Dark tracers could reveal best cancer treatment path
NCT ID NCT07196384
Summary
This study is testing a new imaging technique to help doctors predict which esophageal cancer patients will respond to immunotherapy. Researchers will use special 'glow-in-the-dark' tracers and a camera during an endoscopy to look for specific proteins in the tumor. The goal is to gather information that could help match future patients with the most effective treatments, not to directly treat the participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.